companydata.dkcompanydata.dk

BIOFAC A/S: Financial statements 2020

CVR: 62550511

Source: annual report 2020, Danish Business Authority

01/07/2019 – 30/06/2020

BIOFAC A/S (CVR 62550511) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 23,387,345 and a net result of DKK -4,193,411 compared with DKK -7,949,743 the year before. That is an increase of 62.4% compared with the year before. Equity in the 2020 report amounted to DKK 19,731,993. The solvency ratio was 12%. The company had 68 employees in the financial year.

Gross Profit
DKK 23,387,345
Profit/Loss
DKK -4,193,411
Equity
DKK 19,731,993
Total Assets
DKK 164,460,179
Employees
68

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-23.4 mio.-4.2 mio.19.7 mio.68
2019-14.4 mio.-7.9 mio.23.9 mio.71
2018-16.4 mio.-7.3 mio.11.9 mio.68
201755 mio.19.7 mio.-3.8 mio.4.2 mio.60
201644.2 mio.19.6 mio.-934 t.10.3 mio.57

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is BIOFAC A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Svend Blankholm leaves the board of BIOFAC A/SFeb 13, 2020

As of February 13, 2020, Svend Blankholm has left the board of directors of BIOFAC A/S.

About BIOFAC A/S

BIOFAC A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1934. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Peter Rørvig. The board consists of Helle Rørvig, Niels Ulrik Heine and Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. The company has 83 employees (2026). In 2025, the company reported a gross profit of DKK 73,647,426 and a net result of DKK -3,775,890 compared with DKK 332,520 the year before. Equity in the 2025 report amounted to DKK 10,810,382.

Source: annual report 2025, Danish Business Authority